Ahmed Salah Arafa *, Ahmed yehia , Alaa fiad
1Magdy Salah El-Din Hussain, 1Hisham Wefky Anwar, 2Mostafa Mahmoud El Nakib, 1Amr Essam Mosaad*
Doaa Ahmed Mansour M.D., FRCS Eng
Moutaz Ragab1,Mohamed Hamed Abouelfadl1, Mahmoud M. Marei 1
Moutaz Ragab, Mahmoud M. Marei ,Mohamed Hamed Abouelfadl
Wadie Boshra MD, MRCS, Mohammed Attia Elsayed MD, Ahmed S. M. Omar MD.
Mahmoud Alhussinia, M. Ashraf Balbaab, Ahmed Tarek Awada, Tamer Abdelbakia
Ahmed El-Gendi1, Mohamed El-Shafei2, Essam Bedewy3
Elsobky A, MD
Ahmed Sawaby1, Islam Atta2, Amr El Abd3,Mohsen Ahmed Abdelmohsen4
Ayman M. A. Osman1 MD, MRCS (Eng); Hytham H. Mohey1 M.Sc.; Ahmed M. Ghobashy1 MD
Nezar A. Abo Halawa1*, Ahmed El-Abd Ahmed2, Sawsan A. Elkhateeb3, Galal H. Galal3
Nezar A. Abo Halawa1*, Mohamed Yousef Batikhe2
Wadie Boshra MD, MRCS, Abdallah Hamed Ibrahim Khalil MD, Fawzy Salah Fawzy MD, MRCS
Hussein Ali Mustafa Abdel-Motaleb, Mohammed Ahmed Mohammed Ismail, Islam Mohamed Nabil Atta & Ahmed Mohammed Ahmed Abdel-Rahim*
Reem Mohamed Ali Abd El Reheem El Masry1, Sameh Abd Allah Maaty2, Anwar A. El Shenawy3, Fawzy Salah Fawzy2
Impact of Roux-en-Y gastric bypass and sleeve gastrectomy on three common co-morbidities in morbidly obese Egyptian patients: A randomized comparative study
Objectives: Several co-morbidities may be associated with obesity. The aim of this prospective,
randomized, uncontrolled study is to compare between laparoscopic Roux-en-Y gastric bypass (LRYGB)
and laparoscopic sleeve gastrectomy (LSG) in terms of their impact on 3 common obesity-related comorbidities: hypertension, diabetes mellitus (DM) and gastroesophageal reflux disease (GERD). Methods:
Over a 20-month period, 50 morbidly obese patients were randomly allocated into one of two groups (A &
B). Group A patients (n=25) underwent LRYGB, whereas group B patients (n=25) underwent LSG.
Patients were followed up for 6 months. Primary endpoints included percentage of excess weight loss
(%EWL) and impact on 3 obesity-related co-morbidities: hypertension, DM and GERD. Results: The
%EWL was significantly higher in group A at 6 months postoperatively (61.1 ± 11.95 kg/m2
) compared to
group B (57.17 ± 8.36 kg/m2
); P=0.007. The rates of remission of hypertension were higher in group A
(60%) compared to group B (25%). Complete resolution or improvement of type 2 DM was achieved in
both groups. Four / 5 patients with preoperative GERD symptoms in group A (80%) had complete relief of
their symptoms at 6 months, compared to 3 / 6 patients in group B (50%). Conclusion: Both LRYGB and
LSG are effective in terms of short-term weight loss. However, LRYGB provides better weight loss at 6
months after surgery. Both LRYGB and LSG are associated with excellent and comparable rates of type 2
DM resolution / improvement, but the rates of remission of hypertension and relief of GERD symptoms
appear to be higher after LRYGB.
Keywords: Obesity; Roux-en-Y gastric bypass; sleeve gastrectomy; co-morbidities.